Robert W. Baird Increases Accendra Health (NYSE:ACH) Price Target to $6.00

Accendra Health (NYSE:ACH) had its price objective increased by equities researchers at Robert W. Baird from $5.00 to $6.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s price objective would suggest a potential upside of 52.67% from the company’s current price.

Other equities analysts have also recently issued reports about the company. Weiss Ratings began coverage on Accendra Health in a report on Wednesday, April 8th. They issued a “sell (e+)” rating on the stock. Zacks Research upgraded Accendra Health from a “strong sell” rating to a “hold” rating in a report on Tuesday, April 21st. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $6.00.

Accendra Health Stock Performance

Shares of NYSE ACH opened at $3.93 on Tuesday. The firm has a market capitalization of $300.41 million, a P/E ratio of -0.28, a P/E/G ratio of 2.91 and a beta of 1.70. Accendra Health has a 52-week low of $1.84 and a 52-week high of $9.55.

Accendra Health (NYSE:ACH) last issued its earnings results on Monday, May 11th. The company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. The business had revenue of $627.78 million for the quarter. Accendra Health had a negative return on equity of 50.04% and a negative net margin of 23.32%. As a group, research analysts expect that Accendra Health will post 0.6 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. Dimensional Fund Advisors LP acquired a new stake in Accendra Health during the first quarter valued at $5,943,000. Allspring Global Investments Holdings LLC bought a new position in shares of Accendra Health in the first quarter worth about $239,000. Bank of New York Mellon Corp bought a new position in Accendra Health during the first quarter valued at about $592,000. Hsbc Holdings PLC bought a new position in Accendra Health during the first quarter valued at about $34,000. Finally, Abel Hall LLC bought a new position in Accendra Health during the first quarter valued at about $44,000.

Accendra Health Company Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.